[Other] Outcomes in Patients with Chronic Myeloid Leukemia in the Chronic Phase Randomized to Dasatinib or Imatinib after Suboptimal Responses to 3 Months of Imatinib Therapy: Final 5-Year Results from DASCERN |
|
This post will be closed automatically in 2026-08-23 02:10
Reward56points
|
20
The Thorny History of the Holotype of Rinelepis histrix Valenciennes, 1840 (Siluriformes: Loricariidae), an Eighteenth-Century Naturalist Relic
20
Composition-Controlled Band Alignment and Cl-Mediated Surface Stabilization of ZnSeTe Quantum Dots for Efficient and Stable QLEDs
20
Endovascular versus hybrid interventions for steno-occlusive lesions of the iliofemoral segment (a pilot prospective randomized trial)
20
Belgian military spending: A narrative of decline, stagnation, and recent reversal
20
Donor cell-derived haematological neoplasms after allogeneic haematopoietic cell transplantation: recommendations from the EBMT Practice Harmonisation and Guidelines Committee
